Virtus ETF Advisers’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-44,300
| Closed | -$91K | – | 435 |
|
|
2022
Q1 | $91K | Sell |
44,300
-2,631
| -6% | -$5.41K | 0.04% | 318 |
|
|
2021
Q4 | $176K | Sell |
46,931
-419
| -0.9% | -$1.57K | 0.07% | 258 |
|
|
2021
Q3 | $245K | Sell |
47,350
-2,469
| -5% | -$12.8K | 0.11% | 222 |
|
|
2021
Q2 | $212K | Sell |
49,819
-23,418
| -32% | -$99.7K | 0.09% | 303 |
|
|
2021
Q1 | $389K | Buy |
73,237
+1,283
| +2% | +$6.82K | 0.16% | 187 |
|
|
2020
Q4 | $388K | Buy |
71,954
+40,945
| +132% | +$221K | 0.16% | 157 |
|
|
2020
Q3 | $247K | Sell |
31,009
-4,232
| -12% | -$33.7K | 0.13% | 264 |
|
|
2020
Q2 | $353K | Buy |
+35,241
| New | +$353K | 0.17% | 261 |
|
|
2019
Q2 | – | Sell |
-50,655
| Closed | -$218K | – | 436 |
|
|
2019
Q1 | $218K | Sell |
50,655
-7,568
| -13% | -$32.6K | 0.46% | 85 |
|
|
2018
Q4 | $335K | Buy |
58,223
+20,620
| +55% | +$119K | 0.06% | 91 |
|
|
2018
Q3 | $510K | Sell |
37,603
-27,618
| -42% | -$375K | 0.05% | 118 |
|
|
2018
Q2 | $774K | Buy |
+65,221
| New | +$774K | 0.68% | 48 |
|
|
2016
Q4 | – | Sell |
-26,974
| Closed | -$190K | – | 177 |
|
|
2016
Q3 | $190K | Hold |
26,974
| – | – | 0.09% | 140 |
|
|
2016
Q2 | $220K | Sell |
26,974
-1,208
| -4% | -$9.85K | 0.16% | 126 |
|
|
2016
Q1 | $229K | Buy |
+28,182
| New | +$229K | 0.32% | 69 |
|